Page last updated: 2024-08-25

quindoxin and Breast Neoplasms

quindoxin has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
El-Sabban, M; El-Sitt, S; Gali-Muhtasib, H; Ghattass, K; Haddadin, MJ; Rayes, S; Zibara, K	1

Other Studies

1 other study(ies) available for quindoxin and Breast Neoplasms

Article	Year
The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway. Molecular cancer, 2014, Jan-24, Volume: 13 Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Quinoxalines; RNA, Small Interfering; Signal Transduction; Transfection; Xenograft Model Antitumor Assays	2014

Article

Year

The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.

Molecular cancer, 2014, Jan-24, Volume: 13

Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Quinoxalines; RNA, Small Interfering; Signal Transduction; Transfection; Xenograft Model Antitumor Assays

2014